Athanor Capital’s Dyne Therapeutics DYN Stock Holding History

Athanor Capital’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,738	Closed	-$225K	–	880
2020 Q4	$225K	Buy	+10,738	New	+$212K	0.01%	632

Other funds holding DYN

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Athanor Capital's DYN Position: Q1 2021 in Review

Athanor Capital sold out of Dyne Therapeutics (DYN) in Q1 2021, closing a stake of 10,738 shares — an estimated $225K sold.

Athanor Capital first reported a position in DYN in Q4 2020 and held it in 1 quarter. The position peaked at $225K in Q4 2020. 75 funds tracked by Wall St. Rank hold DYN as of Q1 2021.

Athanor Capital reported no remaining Dyne Therapeutics position as of Q1 2021 after selling out during the quarter.
Athanor Capital sold 10,738 Dyne Therapeutics shares in Q1 2021, an estimated $225K.
Athanor Capital first reported a position in Dyne Therapeutics in Q4 2020 and held it in 1 quarter.
Athanor Capital's Dyne Therapeutics position peaked at $225K in Q4 2020.
75 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.